MRD Monitoring in Acute Lymphoblastic Leukemia
0 Views
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
-
Category
Show more
Facebook Comments
No comments found